Outset Medical, Inc. (OM)

Outset Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	35.51	71.84	76.53	215.66	328.28	37.67
Short-Term Investments	194.74	134.82	214.28	157.14	19.9	33.15
Cash & Cash Equivalents	230.25	206.65	290.81	372.8	348.18	70.82
Cash Growth	-8.82%	-28.94%	-21.99%	7.07%	391.64%	-50.40%
Receivables	36.48	32.98	28.07	25.6	6.47	3.91
Inventory	55.84	49.22	51.48	39.19	18.38	4.6
Other Current Assets	2.83	2.37	3.29	-27.78	-27.12	0.32
Total Current Assets	325.39	291.22	373.65	409.8	345.91	79.65
Property, Plant & Equipment	16.98	18.65	21.99	20.2	23.25	7.9
Other Long-Term Assets	3.87	3.93	4.48	33.47	34.67	0.83
Total Long-Term Assets	20.85	22.58	26.47	53.66	57.92	8.72
Total Assets	346.24	313.8	400.12	463.46	403.83	88.37
Accounts Payable	6.77	5.83	0.6	1.76	4.95	4.96
Deferred Revenue	13.03	11.83	8.81	6.65	3.77	1.02
Current Debt	1.64	1.59	1.32	1.15	0.88	7.5
Other Current Liabilities	29.23	36.08	41.22	42.13	27.09	11.43
Total Current Liabilities	50.67	55.32	51.95	51.7	36.69	24.91
Long-Term Debt	200.87	134.6	101.91	36.66	37.72	21.56
Other Long-Term Liabilities	1.51	1	0.26	1.03	0.81	4.64
Total Long-Term Liabilities	202.37	135.59	102.18	37.69	38.53	26.2
Total Liabilities	253.04	190.92	154.13	89.38	75.22	51.11
Total Debt	202.51	136.19	103.23	37.81	38.6	29.06
Debt Growth	96.49%	31.93%	173.05%	-2.06%	32.82%	2.49%
Retained Earnings	-1,001.69	-961.75	-788.95	-625.99	-494.06	-372.57
Comprehensive Income	-0.26	0.07	-0.56	-0.18	0	0.02
Shareholders' Equity	93.2	122.89	245.99	374.08	328.61	-372.19
Net Cash / Debt	27.74	70.47	187.58	334.99	309.58	41.76
Net Cash / Debt Growth	-81.44%	-62.44%	-44.00%	8.21%	641.33%	-63.51%
Net Cash Per Share	0.54	1.42	3.89	7.35	18.93	48.67
Working Capital	274.72	235.9	321.7	358.11	309.22	54.74
Book Value Per Share	1.83	2.48	5.11	8.21	20.09	-433.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).